⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OVID News
Ovid Therapeutics Inc. Common Stock
Form 8-K
sec.gov
OVID
Ovid Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
OVID
Form 8-K
sec.gov
OVID
Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors
globenewswire.com
OVID
Form 8-K
sec.gov
OVID
Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
globenewswire.com
OVID
Form 8-K
sec.gov
OVID
Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14
globenewswire.com
OVID
Form 8-K
sec.gov
OVID
Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
OVID